Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > PrinceOfCut
View:
Post by RetailRube on Jul 16, 2015 2:06pm

PrinceOfCut

Prince, I find your posts difficult to read.  I don't understand everything you say, usually because you use acronyms.  That leads me to assume you come from a career in biotech, maybe as a securities analyst, or maybe you used to work for Bioniche.  We get your point.  You don't like the stock.  Why keep banging away at this?  Don't you have anything better to do in the middle of a beautiful summer day?
Comment by somweyungguy on Jul 16, 2015 2:18pm
Isn't "princeofcult" you Rube?? ; - ) I think we're all aware of your many handles here and on other places you've been "installed" Sqr
Comment by DamnYankees on Jul 16, 2015 2:46pm
Prince, don't listen to the clowns here. This board is full of a bunch of retreads that bought in years ago on a long shot cow vaccine and have been stuck in this burning warehouse with chained doors ever since. If you want to buy in it will drop into the low-mid 20s in the next month or so, when the desperation financing is announced. I know that there is little no promotion/IR effort so don& ...more  
Comment by princeofcut on Jul 16, 2015 3:06pm
dam, re your prediction of mid-$0.20's as relevent to me as beached guy's constant prediction of parternship just around the corner (for the last three years)...do you believe MCNA will get an RTF or not???
Comment by DamnYankees on Jul 16, 2015 3:23pm
Prince, Who knows whether the filing will be accepted or not.  I have no opinion on FDA procedural matters but operate under the assumption that it will. However, an inquisitive type such as yourself may want to defer to the company analysts and or the readily available IR team. Have you had a chance to read the latest opinions of Telesta's analysts? No, neither have I.
Comment by princeofcut on Jul 16, 2015 3:47pm
dam, thanks for the laugh honest analyst is an oxymoron (only David Miller ex of Biotech  Stock Research did i ever have faith in and he made me and many others a lot of $'s) aren't most just moneywhores and internal IR, never talk to em as they only pump and pump and pump and pump and pump.. does everyone on this MB other than me have a hidden agenda...and all this angst and intrigue ...more  
Comment by princeofcut on Jul 16, 2015 3:03pm
ROTFLMAO..Rube paranoia will destroya and so now i conclude Rube is a well chosen NIC..but no, no, no..hopefully in your real life you are a bit more sane...at $0.32 i am neutral on TST and trying to asses chance of approval, no more no less..but this MB is so full of you bagholders and Rubes and fraudsters and...it really is quite entertaining..i guess the previous failed CEO of BNC did a real ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities